|
AKAP8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.085840E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.150400E-02 |
| Normal-vs-Stage2 |
8.263700E-02 |
| Normal-vs-Stage3 |
2.031400E-01 |
| Normal-vs-Stage4 |
9.760700E-04 |
| Stage1-vs-Stage2 |
7.826200E-01 |
| Stage1-vs-Stage3 |
9.337600E-01 |
| Stage1-vs-Stage4 |
3.180500E-02 |
| Stage2-vs-Stage3 |
8.035600E-01 |
| Stage2-vs-Stage4 |
2.131600E-01 |
| Stage3-vs-Stage4 |
1.546390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.395900E-03 |
| Normal-vs-AfricanAmerican |
6.222100E-02 |
| Normal-vs-Asian |
1.543820E-01 |
| Caucasian-vs-AfricanAmerican |
7.257000E-01 |
| Caucasian-vs-Asian |
9.177400E-01 |
| AfricanAmerican-vs-Asian |
8.206000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.692060E-02 |
| Normal-vs-Female |
2.088400E-02 |
| Male-vs-Female |
7.471200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.333600E-02 |
| Normal-vs-Extreme_Weight |
4.359600E-03 |
| Normal-vs-Obese |
1.524030E-01 |
| Normal-vs-Extreme_Obese |
6.422000E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.274400E-01 |
| Normal_Weight-vs-Obese |
2.952800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.100400E-01 |
| Extreme_Weight-vs-Obese |
2.174600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.022400E-01 |
| Obese-vs-Extreme_Obese |
2.225200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.544600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.436200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.238010E-03 |
| Normal-vs-Age(81-100Yrs) |
1.645220E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.035600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.586400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.300400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.698300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.252320E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.065160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.895050E-01 |
| Normal-VS-Type2 PRCC |
2.62709999998556E-06 |
| Normal-VS-KIRP CIMP |
5.878400E-03 |
| Normal-VS-Unclassified PRCC |
1.594160E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.37660000002027E-06 |
| Type1 PRCC-VS-KIRP CIMP |
1.186980E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.169200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.070000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.917500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.987400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.356100E-03 |
| Normal-vs-N1 |
8.813700E-02 |
| Normal-vs-N2 |
5.181200E-03 |
| N0-vs-N1 |
3.384200E-01 |
| N0-vs-N2 |
3.067800E-01 |
| N1-vs-N2 |
1.534970E-01 |
|
|
